Gainers
- Exicure (NASDAQ:XCUR) shares moved upwards by 36.3% to $0.14 during Wednesday's pre-market session. The company's market cap stands at $17.7 million.
- Enveric Biosciences (NASDAQ:ENVB) stock moved upwards by 24.28% to $0.26. The company's market cap stands at $13.5 million.
- Avalo Therapeutics (NASDAQ:AVTX) shares increased by 18.89% to $0.35. The market value of their outstanding shares is at $39.1 million. The company's, Q1 earnings came out 4 days ago.
- Zai Lab (NASDAQ:ZLAB) stock rose 17.79% to $30.91. The company's market cap stands at $3.0 billion. As per the press release, Q1 earnings came out yesterday.
- Regulus Therapeutics (NASDAQ:RGLS) shares moved upwards by 17.17% to $0.2. The market value of their outstanding shares is at $29.3 million.
- Acutus Medical (NASDAQ:AFIB) stock moved upwards by 16.77% to $1.15. The market value of their outstanding shares is at $32.5 million.
Losers
- Arcus Biosciences (NYSE:RCUS) stock declined by 25.4% to $17.9 during Wednesday's pre-market session. The market value of their outstanding shares is at $1.2 billion. The company's, Q1 earnings came out 2 days ago.
- ITeos Therapeutics (NASDAQ:ITOS) stock declined by 18.77% to $20.82. The company's market cap stands at $739.6 million.
- Akanda (NASDAQ:AKAN) shares declined by 16.55% to $1.16. The market value of their outstanding shares is at $33.5 million.
- Trevena (NASDAQ:TRVN) shares declined by 15.74% to $0.24. The market value of their outstanding shares is at $40.0 million. The company's, Q1 earnings came out today.
- Inovio Pharmaceuticals (NASDAQ:INO) stock declined by 15.67% to $2.1. The market value of their outstanding shares is at $465.7 million. As per the news, the Q1 earnings report came out yesterday.
- Evaxion Biotech (NASDAQ:EVAX) shares declined by 12.0% to $1.98. The market value of their outstanding shares is at $45.9 million. As per the news, the Q1 earnings report came out today. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
